GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DNA Group (TR) Ltd (XTAE:DNA) » Definitions » Common Stock

Switch to:

DNA Group (TR) (XTAE:DNA) Common Stock : ₪79.19 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is DNA Group (TR) Common Stock?

DNA Group (TR)'s quarterly common stock increased from Dec. 2022 (₪80.11 Mil) to Jun. 2023 (₪141.09 Mil) but then declined from Jun. 2023 (₪141.09 Mil) to Dec. 2023 (₪79.19 Mil).

DNA Group (TR)'s annual common stock increased from Dec. 2021 (₪54.33 Mil) to Dec. 2022 (₪80.11 Mil) but then declined from Dec. 2022 (₪80.11 Mil) to Dec. 2023 (₪79.19 Mil).

DNA Group (TR) Common Stock Historical Data

The historical data trend for DNA Group (TR)'s Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DNA Group (TR) Common Stock Chart

DNA Group (TR) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

Premium Member Only

Premium Member Only

69.64

71.86

54.33

80.11

79.19

DNA Group (TR) Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Common Stock	Get a 7-Day Free Trial															54.33	140.25	80.11	141.09	79.19

DNA Group (TR) Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

DNA Group (TR) (XTAE:DNA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DNA Group (TR) Ltd (XTAE:DNA) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shimon Hatirsi Street 43, Tel Aviv, ISR, 62492

Website

DNA Group (TR) Ltd invests in biomed companies and has also started to engage in profitable real estate in England.

DNA Group (TR) (XTAE:DNA) Headlines

From GuruFocus

GreenLab Selects Ginkgo Enzyme Services to Develop Novel Enzyme That Breaks Down 'Forever Chemicals'

By PRNewswire • 12-19-2023

Nosh.bio Leverages Ginkgo Strain Optimization Services to Enhance Meaty Taste of Mycoprotein

By PRNewswire • 10-02-2023

Ginkgo Bioworks Announces Date of Third Quarter 2023 Results Presentation

By PRNewswire • 11-01-2023

Ginkgo Bioworks Completes Program with Biogen to Boost Productivity of Gene Therapy Manufacturing Platform

By PRNewswire • 01-04-2024

Government of Serbia and Ginkgo Bioworks Announce Bioeconomy Collaboration in BIO4 Campus

By PRNewswire • 10-19-2023

Concentric by Ginkgo to Support CDC-Funded Consortium to Develop New AI-Based Technologies for Epidemic Forecasting

By PRNewswire • 10-05-2023

Concentric By Ginkgo and Texas A&M University Awarded USDA NIFA AFRI Grant to Conduct Genomic Animal Research to Prevent Zoonotic Disease Spillover

By PRNewswire • 09-29-2023

Director Christian Henry Sells 4,499 Shares of Ginkgo Bioworks Holdings Inc (DNA)

By GuruFocus Research • 10-05-2023

Agrivalle and Ginkgo Bioworks Enter Multiyear Strategic Partnership to Accelerate Next-Gen Ag Biological Products

By PRNewswire • 12-08-2023

QL AG Announces Partnership with Ginkgo Bioworks to Develop Dairy Proteins

By PRNewswire • 10-12-2023

Home About Jobs Site Map Term of Use Privacy Policy Mobile App Referral Program Partner Program FAQ Contact Us 中文 All-In-One Screener
Stock List Guru List Insider List Insider Trade Economic Indicators Industry Data DCF Calculator Discussion Board Plans Excel Add-In Google Sheets Add-on
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.